title: Humoral Immune Response and Allograft Function in Kidney Transplantation.
abstract: HLA antibodies can damage a kidney transplant. In January 2013, consensus guidelines from The Transplantation Society were published regarding technical aspects of HLA antibody determination, as well as their potential significance in the pre- and posttransplantation periods. During the past 2 years, new studies have been reported, but controversies remain. In this article, these new data related to HLA antibodies in kidney transplantation are reviewed and compared to relevant prior research. Pretransplantation sensitization issues are discussed, including the new more sensitive assays (flow cytometry and solid-phase immunoassays such as Luminex single-antigen bead assays). A positive complement-dependent cytotoxicity crossmatch remains an absolute contraindication to transplantation, although a positive flow cytometry crossmatch is only a relative contraindication. Positivity only by solid-phase assays increases the risk for acute rejection and transplant loss, but acceptable cutoffs are not defined. The sensitizing effect of red blood cell transfusions is substantiated. Following allograft failure, continued immunosuppression decreases the risk of sensitization, whereas overall, the effect of nephrectomy remains uncertain. Regarding the posttransplantation period, new data are available concerning the timing and significance of donor-specific antibodies (DSA). Whereas some centers report DSA appearance after years, others detect DSA within months. The prominence of class II DSA, especially DQ, in the posttransplantation period is noted. The relevance of non-HLA antibodies is discussed, including anti-endothelial cell antibodies, major histocompatibility complex class I chain-related protein A antibodies, and angiotensin II type 1 receptor autoantibodies.
authors.affiliation: Division of Nephrology, Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA. Electronic address: kidneys@comcast.net.
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Filippone
authors.affiliation: Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA.
authors.forename: John L
authors.initials: JL
authors.lastname: Farber
mesh_terms: D064591:Allografts; D000906:Antibodies / Q000276:immunology*; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D006680:HLA Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D056724:Immunity, Humoral / Q000276:immunology*; D016030:Kidney Transplantation; D014184:Transplantation, Homologous
chemical_list: D000906:Antibodies; D006680:HLA Antigens
keywords: HLA antibodies; Kidney transplantation; MICA; RBC transfusion; acute rejection; allograft function; allograft nephrectomy; crossmatching; donor-specific antibody (DSA); graft survival; immune response; kidney transplant recipient (KTR); non-HLA antibodies; renal transplant failure; sensitization; solid-phase immunoassay